At a Glance
T. Rowe Price fund manager David Giroux has publicly removed Tesla (TSLA) from his version of the Magnificent Seven, swapping in another large-cap tech name while arguing Big Tech as a group is not in a bubble. The bigger signal is where he sees value next: healthcare and utilities.
Why It Matters Now
When a respected capital-appreciation manager singles out one of the seven megacaps to drop, the message is relative, not absolute. Giroux is not calling the whole cohort overvalued — he explicitly rejects the bubble label. Instead he is saying Tesla no longer earns its seat versus peers whose earnings power is more visible. That distinction matters for investors who treat the Magnificent Seven as a single trade: the group is increasingly dispersing, and Tesla sits at the weakest end on conventional valuation, because its multiple still prices in autonomy, robotaxi and energy optionality rather than current auto margins under price-cut pressure.
The rotation call into healthcare and utilities is the actionable part. Healthcare offers durable cash flows and depressed multiples after years of underperformance, while utilities have re-rated as the unglamorous, regulated beneficiaries of surging electricity demand from AI data centers. That is a way to stay long the AI build-out without paying megacap-tech multiples — a hedge against the same concentration risk that makes a Tesla-heavy index nervous.
FAQ
- Does this mean sell Tesla? No. Giroux is reweighting his preferred basket, not issuing a target; it reflects relative conviction versus other megacaps.
- Is he bearish on Big Tech? The opposite — he says the group is not in a bubble, so this is selectivity within tech, not an exit.
- Why healthcare and utilities? Low valuations and steady cash flows in healthcare; AI-driven power demand and regulated returns in utilities.
- Who replaces Tesla? He crowns another large tech name in its place, underscoring this is a swap inside the cohort.
Related Stocks and Sectors
- TSLA — the subject; flagged as the relative laggard in the megacap group on valuation versus earnings.
- Healthcare — cited as undervalued with durable cash flows, a defensive value rotation target.
- Utilities — framed as an AI-power proxy benefiting from data-center electricity demand.
- NVDA, MSFT, AAPL, GOOGL, META, AMZN — the remaining megacaps whose relative standing rises if Tesla is the weak link.
What to Watch
- Tesla's next delivery numbers and automotive gross margin trend versus its still-rich multiple.
- Progress and timelines on robotaxi and full self-driving, the catalysts that justify the premium.
- Utility capex and power-purchase deals tied to AI data centers.
- Healthcare earnings and any policy headlines that could re-rate the sector.
Overall Outlook
The bull case for Tesla rests on monetizing autonomy and energy, which no rival megacap can match if it works. The risk Giroux highlights is timing and price: investors are paying a software-and-mobility multiple while the cash engine is still a margin-squeezed carmaker. His healthcare-and-utilities tilt is a reminder that value can exist outside the crowded leadership — and that the Magnificent Seven trade is no longer one trade.
Market data check: TSLA
TSLA last traded near $400.49 (+1.04%). Our composite signal — blending price momentum and news flow — reads 🟡 neutral. Price momentum scores 58/100.
Data as of publication. Price via market feeds; for reference only, not investment advice.
This article was independently written by OneDayTrading from public reporting. Read the original (MarketWatch)
